Friday, March 15, 2019

Pharma Reviews: Jan Aushadhi scheme may disrupt domestic pharma market

The report by Edelweiss expects that around Rs 6,000 crore of the Bureau of Pharma PSUs of India (BPPI) drugs could adversely impact around Rs ...
Read more: Jan Aushadhi scheme may disrupt domestic pharma market